Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 21, 2019 - Issue 2
Submit an article Journal homepage
436
Views
19
CrossRef citations to date
0
Altmetric
Case Reports

Granuloma as a complication of polycaprolactone-based dermal filler injection: ultrasound and histopathology studies

Ewa SkrzypekDepartment of History of Medicine, Medical University of Warsaw, Warsaw, Poland
,
Barbara GórnickaDepartment of Pathology, Medical University of Warsaw, Warsaw, Poland
,
Daisy Miriam SkrzypekDepartment of Forensic Medicine, Medical University od Warsaw, Warsaw, Poland
&
Mlosek Robert KrzysztofDepartment of Diagnostic Imaging of the II Medical Faculty of the MedicalUniversity of Warsaw, Warsaw, PolandCorrespondence[email protected]
Pages 65-68 | Received 10 Oct 2017, Accepted 18 Mar 2018, Published online: 14 May 2018

References

  • Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003;27(5):354–66. discussion 367. Epub 2003 Dec 4.
  • Kim JH, Ahn DK, Jeong HS, Suh IS. Treatment algorithm of complications after filler injection: based on wound healing process. J Korean Med Sci. 2014;29(Suppl 3):176–S182. doi:10.3346/jkms.2014.29.S3.S176.
  • Glogau RG, Knott HM. Fillers: evolution, regression, and the future. In: Carruthers J, Carruthers A, Dover JS, Alam M (eds).Procedures in Cosmetic Dermatology: Soft tissue augmentation. New York: Saunders Elsevier; 2013: 3–9.
  • Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. PlastSurgNurs. 2015 Jan-Mar;35(1):13–32. doi:10.1097/PSN.0000000000000087.
  • Carruthers J, Carruthers A, Humphrey S. Introduction to fillers. Plast Reconstr Surg. 2015;136(5Suppl):120S–31S. doi:10.1097/PRS.0000000000001770.
  • Galadari H, Van Abel D, Al Nuami K, Al Faresi F, Galadari I. A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabialfolds. J Cosmet Dermatol. 2015;14(1):27–32. doi:10.1111/jocd.12126. Epub 2015 Jan 6.
  • De Melo F, Marijnissen-Hofsté J. Investigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine. Dermatol Ther (Heidelb). 2012;2(1):13. doi:10.1007/s13555-012-0013-7. Epub 2012 Sep 28.
  • Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial. Dermatol Surg. 2013;39(3 Pt 1):457–63. doi:10.1111/dsu.12054. Epub 2013 Jan 25.
  • Figueiredo VM. A five-patient prospective pilot study of a polycaprolactone-based dermal filler for hand rejuvenation. J Cosmet Dermatol. 2013;12(1):73–77. doi:10.1111/jocd.12020.
  • Kim JA, Van Abel D. Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler. J Cosmet Laser Ther. 2015;17(2):99–101. doi:10.3109/14764172.2014.968586. Epub 2014 Oct 27.
  • EllansėTM. AQTIS Medical™. http://www.elanse.com.
  • Morhenn VB, Lemperle G, Gallo RL. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg. 2002 Jun;28(6):484–90.
  • Laeschke K. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg. 2004 Dec;23(4):214–17. Review.
  • Nicolau PJ, Marijnissen-Hofsté J. Neocollagenesis after injection of a polycaprolactone based dermal filler in a rabbit. Eur J Aesthetic Med Dermatol. 2013;3(1):19–26.
  • Gritzalas K. Preliminary results in using a new dermal filler based on polycaprolactone. Eur J Aesthetic Med Dermatol. 2011;1(1):22–26.
  • De Melo F, Nicolau P, Piovano L, Lin SL, Baptista-Fernandes T, King MI, Camporese A, Hong K, Khattar MM, Christen MO. Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®). Clin Cosmet Investig Dermatol. 2017;10:431–40. doi:10.2147/CCID.S145195.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.